NCT07395258
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07395258
Title A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | FRA | ESP | DEU

Facility Status City State Zip Country Details
Indiana University NOT_YET_RECRUITING Indianapolis Indiana 46202 United States Details
University of Minnesota RECRUITING Minneapolis Minnesota 55455 United States Details
The University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center NOT_YET_RECRUITING Seattle Washington 98109 United States Details
CTR Leon Berard NOT_YET_RECRUITING Lyon 69373 France Details
Institut Gustave Roussy NOT_YET_RECRUITING Villejuif 94800 France Details
Universitätsklinikum Heidelberg NOT_YET_RECRUITING Heidelberg 69120 Germany Details
Hospital Clínic de Barcelona NOT_YET_RECRUITING Barcelona 08036 Spain Details
Hospital Clinico De Valencia (INCLIVA) NOT_YET_RECRUITING Valencia 46010 Spain Details
Karolinska Universitetssjukhuset Stockholm NOT_YET_RECRUITING Stockholm 17177 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field